These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 30080497)

  • 1. To Improve COPD Care: A New Instrument Is Needed to Assess Dyspnea.
    Mahler DA; Sethi S
    Chest; 2018 Aug; 154(2):235-237. PubMed ID: 30080497
    [No Abstract]   [Full Text] [Related]  

  • 2. The need to address increasing opioid use in elderly COPD patients.
    Vozoris NT; O'Donnell DE
    Expert Rev Respir Med; 2016; 10(3):245-8. PubMed ID: 26783198
    [No Abstract]   [Full Text] [Related]  

  • 3. Agreement between a simple dyspnea-guided treatment algorithm for stable COPD and the GOLD guidelines: a pilot study.
    Cabrera C; Casanova C; Martín Y; Mirabal V; Sánchez Mdel C; Álvarez F; Juliá G; Cabrera-Navarro P; García-Bello MÁ; Marín JM; de-Torres JP; Divo M; Celli B
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1217-22. PubMed ID: 27354780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in pharmacotherapy for dyspnea in COPD.
    Raghavan N; Webb K; Amornputtisathaporn N; O'Donnell DE
    Curr Opin Pharmacol; 2011 Jun; 11(3):204-10. PubMed ID: 21450522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New physiological insights into dyspnea and exercise intolerance in chronic obstructive pulmonary disease patients.
    Laveneziana P; Guenette JA; Webb KA; O'Donnell DE
    Expert Rev Respir Med; 2012 Dec; 6(6):651-62. PubMed ID: 23234451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of pharmacologic treatment based on airflow limitation and breathlessness on daily physical activity in patients with chronic obstructive pulmonary disease.
    Minakata Y; Morishita Y; Ichikawa T; Akamatsu K; Hirano T; Nakanishi M; Matsunaga K; Ichinose M
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1275-82. PubMed ID: 26170656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breathlessness during exercise in COPD: how do the drugs work?
    Calverley PM
    Thorax; 2004 Jun; 59(6):455-7. PubMed ID: 15170021
    [No Abstract]   [Full Text] [Related]  

  • 8. Three-minute constant rate step test for detecting exertional dyspnea relief after bronchodilation in COPD.
    Borel B; Wilkinson-Maitland CA; Hamilton A; Bourbeau J; Perrault H; Jensen D; Maltais F
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2991-3000. PubMed ID: 27942208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of extrafine beclometasone/formoterol (BDP/F) on lung function, dyspnea, hyperinflation, and airway geometry in COPD patients: novel insight using functional respiratory imaging.
    De Backer J; Vos W; Vinchurkar S; Van Holsbeke C; Poli G; Claes R; Salgado R; De Backer W
    J Aerosol Med Pulm Drug Deliv; 2015 Apr; 28(2):88-99. PubMed ID: 25004168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving dyspnea in chronic obstructive pulmonary disease: optimal treatment strategies.
    Rabe KF
    Proc Am Thorac Soc; 2006 May; 3(3):270-5. PubMed ID: 16636097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute exacerbation of COPD].
    Füessl HS
    MMW Fortschr Med; 2014 Jan; 156(1):44-6. PubMed ID: 24930309
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease.
    O'Donnell DE
    Proc Am Thorac Soc; 2006 Apr; 3(2):180-4. PubMed ID: 16565429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ghrelin treatment on exertional dyspnea in COPD: an exploratory analysis.
    Miki K; Maekura R; Nagaya N; Miki M; Kitada S; Yoshimura K; Mori M; Kangawa K
    J Physiol Sci; 2015 May; 65(3):277-84. PubMed ID: 25724656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing dyspnea in advanced chronic obstructive pulmonary disease: balancing all the evidence.
    Mularski RA; Rocker G
    Ann Am Thorac Soc; 2015 Jul; 12(7):978-80. PubMed ID: 26203609
    [No Abstract]   [Full Text] [Related]  

  • 15. 'INSPIRED' approaches to better care for patients with advanced COPD.
    Rocker GM; Cook D
    Clin Invest Med; 2013 Jun; 36(3):E114-20. PubMed ID: 23739664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptoms and impact of COPD assessed by an electronic diary in patients with moderate-to-severe COPD: psychometric results from the SHINE study.
    Kulich K; Keininger DL; Tiplady B; Banerji D
    Int J Chron Obstruct Pulmon Dis; 2015; 10():79-94. PubMed ID: 25609942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding mechanisms and documenting plausibility of palliative interventions for dyspnea.
    Mahler DA
    Curr Opin Support Palliat Care; 2011 Jun; 5(2):71-6. PubMed ID: 21430539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining tiotropium and salmeterol in COPD: Effects on airflow obstruction and symptoms.
    van Noord JA; Aumann JL; Janssens E; Smeets JJ; Zaagsma J; Mueller A; Cornelissen PJ
    Respir Med; 2010 Jul; 104(7):995-1004. PubMed ID: 20303247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of tiotropium and olodaterol on symptoms and patient-reported outcomes in patients with COPD: results from four randomised, double-blind studies.
    Ferguson GT; Karpel J; Bennett N; Clerisme-Beaty E; Grönke L; Voß F; Buhl R
    NPJ Prim Care Respir Med; 2017 Feb; 27(1):7. PubMed ID: 28154373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Greater dyspnea is associated with lower health-related quality of life among European patients with COPD.
    Gruenberger JB; Vietri J; Keininger DL; Mahler DA
    Int J Chron Obstruct Pulmon Dis; 2017; 12():937-944. PubMed ID: 28360517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.